The store will not work correctly when cookies are disabled.
(S)-5-amino-2-(5-hydroxy-1,3-dioxoisoindolin-2-yl)-5-oxopentanoic acid
ID: ALA1939688
PubChem CID: 38988887
Max Phase: Preclinical
Molecular Formula: C13H12N2O6
Molecular Weight: 292.25
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Synonyms: NSC-78623 | NSC-78623|CHEMBL1939688
Canonical SMILES: NC(=O)CC[C@@H](C(=O)O)N1C(=O)c2ccc(O)cc2C1=O
Standard InChI: InChI=1S/C13H12N2O6/c14-10(17)4-3-9(13(20)21)15-11(18)7-2-1-6(16)5-8(7)12(15)19/h1-2,5,9,16H,3-4H2,(H2,14,17)(H,20,21)/t9-/m0/s1
Standard InChI Key: OMADFDXNAFQWOZ-VIFPVBQESA-N
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
7.9607 -25.9948 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.2462 -25.5823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5317 -25.9948 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.2462 -24.7573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9607 -24.3448 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.0469 -23.5243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4338 -22.9723 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.8539 -23.3528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2664 -22.6383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0914 -22.6383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5039 -23.3528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3289 -23.3528 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.0914 -24.0673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2664 -24.0673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7143 -24.6804 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8859 -25.4873 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.5317 -24.3448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8173 -24.7573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1028 -24.3448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1028 -23.5198 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.3883 -24.7573 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
4 2 1 0
4 5 1 0
5 6 1 0
6 7 2 0
6 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
11 13 1 0
13 14 2 0
8 14 1 0
14 15 1 0
5 15 1 0
15 16 2 0
4 17 1 6
17 18 1 0
18 19 1 0
19 20 2 0
19 21 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 292.25 | Molecular Weight (Monoisotopic): 292.0695 | AlogP: -0.29 | #Rotatable Bonds: 5 |
Polar Surface Area: 138.00 | Molecular Species: ACID | HBA: 5 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 2.96 | CX Basic pKa: ┄ | CX LogP: -0.50 | CX LogD: -4.13 |
Aromatic Rings: 1 | Heavy Atoms: 21 | QED Weighted: 0.64 | Np Likeness Score: -0.07 |
References
1. Wang Y, Hess TN, Jones V, Zhou JZ, McNeil MR, Andrew McCammon J.. (2011) Novel inhibitors of Mycobacterium tuberculosis dTDP-6-deoxy-L-lyxo-4-hexulose reductase (RmlD) identified by virtual screening., 21 (23): [PMID:22014548] [10.1016/j.bmcl.2011.09.094] |